DNMT1 and cancer: As the MEK/ERK pathway is widely activated, as a result of RAS or BRAF mutations and others60,61, in human cancer cells, our finding provides a reasonable explanation for widespread transcriptional overexpression of UHRF1 (DNMT1 as well) in various cancers.